| Autor: |
Efron N; Institute of Health and Biomedical Innovation, School of Optometry and Vision Science, Queensland University of Technology, Australia. Electronic address: n.efron@qut.edu.au., Brennan NA; Johnson & Johnson Vision, Inc, Jacksonville, FL, USA., Chalmers RL; Clinical Trial Consultant, Atlanta, GA, USA., Jones L; Centre for Ocular Research & Education (CORE), School of Optometry & Vision Science, University of Waterloo, Waterloo, Ontario, Canada., Lau C; Novartis Pharmaceuticals, East Hanover, NJ, USA., Morgan PB; Eurolens Research, Division of Pharmacy and Optometry, The University of Manchester, UK., Nichols JJ; The University of Alabama at Birmingham, School of Optometry, Birmingham, AL, USA., Szczotka-Flynn LB; University Hospitals Eye Institute, University Hospitals Cleveland Medical Center, Department of Ophthalmology & Visual Sciences, Case Western Reserve University, Cleveland, OH, USA., Willcox MD; School of Optometry and Vision Science, University of New South Wales, Sydney, Australia. |
Full Text from ScienceDirect